Dicerna Pharma (DRNA)

13.10 +0.19 (1.47%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/14/19 *Est.)

Latest Headlines

Form 10-K Dicerna Pharmaceuticals For: Dec 31 March 13, 2019 5:32 PM - SEC Filing Dicerna Pharma (DRNA) PT Raised To $26 At SunTrust On Pivotal Phase I Launch March 12, 2019 9:04 AM - StreetInsider Dicerna Pharmaceuticals (DRNA) PT Raised to $24 at B.Riley/FBR March 12, 2019 8:57 AM - StreetInsider Dicerna Pharmaceuticals (DRNA) PT Lowered to $22 at H.C. Wainwright March 12, 2019 8:07 AM - StreetInsider Stifel Reiterates Buy Rating on Dicerna Pharmaceuticals (DRNA) March 12, 2019 6:48 AM - StreetInsider Dicerna Pharma (DRNA) Misses Q4 EPS by 7c, Revenues Miss March 11, 2019 4:26 PM - StreetInsider Form 8-K Dicerna Pharmaceuticals For: Mar 11 March 11, 2019 4:09 PM - SEC Filing Dicernaâ„¢ Reports Fourth Quarter and Year Ended December 31, 2018 Financial Results and Provides Corporate Update March 11, 2019 4:05 PM - BizWire Dicerna to Report Fourth Quarter and Year End 2018 Financial Results and Host Conference Call on March 11, 2019 March 4, 2019 4:05 PM - BizWire Dicerna Pharmaceuticals, Inc. Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) March 1, 2019 4:30 PM - BizWire Cowen Starts Dicerna Pharmaceuticals (DRNA) at Outperform February 25, 2019 4:42 PM - StreetInsider Dicerna Pharmaceuticals to Present at Upcoming Investor Conferences February 22, 2019 4:49 PM - BizWire ADDING MULTIMEDIA Dicerna Bolsters Leadership Team to Support Continued Growth February 21, 2019 9:10 AM - BizWire Dicerna Bolsters Leadership Team to Support Continued Growth February 21, 2019 6:30 AM - BizWire Form SC 13G/A Dicerna Pharmaceuticals Filed by: BRIDGER MANAGEMENT, LLC February 14, 2019 4:35 PM - SEC Filing Form SC 13G/A Dicerna Pharmaceuticals Filed by: Cormorant Asset Management, LP February 14, 2019 4:10 PM - SEC Filing Form SC 13G/A Dicerna Pharmaceuticals Filed by: EcoR1 Capital, LLC February 14, 2019 11:39 AM - SEC Filing Form SC 13G/A Dicerna Pharmaceuticals Filed by: RTW INVESTMENTS, LP February 14, 2019 9:27 AM - SEC Filing Form SC 13G/A Dicerna Pharmaceuticals Filed by: FMR LLC February 13, 2019 11:54 AM - SEC Filing Pioneer in Taking RNA Therpeutics Through the Clinic Joins Skyhawk Therapeutics as Chief Medical Officer February 12, 2019 1:17 PM - PR NewsWire Form 5 Dicerna Pharmaceuticals For: Dec 31 Filed by: FAMBROUGH DOUGLAS February 8, 2019 9:02 PM - SEC Filing Form SC 13G Dicerna Pharmaceuticals Filed by: BlackRock Inc. February 8, 2019 6:15 AM - SEC Filing Dicerna Pharmaceuticals, Inc. Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) February 1, 2019 4:30 PM - BizWire Dicerna Pharma (DRNA) Reports First Volunteer Dosing in Phase 1 Clinical Trial of DCR-HBVS Designed for the Treatment of Chronic Hepatitis B Virus January 28, 2019 7:31 AM - StreetInsider Dicerna Announces Dosing of First Volunteer in Phase 1 Clinical Trial of DCR-HBVS Designed for the Treatment of Chronic Hepatitis B Virus January 28, 2019 7:30 AM - BizWire Form 4 Dicerna Pharmaceuticals For: Jan 23 Filed by: KOZIN MARC D January 25, 2019 9:12 PM - SEC Filing Form 4 Dicerna Pharmaceuticals For: Jan 23 Filed by: Protopapas Anna January 25, 2019 9:11 PM - SEC Filing Form 3 Dicerna Pharmaceuticals For: Jan 23 Filed by: KOZIN MARC D January 25, 2019 9:03 PM - SEC Filing Form 3 Dicerna Pharmaceuticals For: Jan 23 Filed by: Protopapas Anna January 25, 2019 9:01 PM - SEC Filing Form 8-K Dicerna Pharmaceuticals For: Jan 23 January 25, 2019 5:30 PM - SEC Filing Dicerna Pharmaceuticals (DRNA) PT Lowered to $23 at Leerink Partners January 25, 2019 8:09 AM - StreetInsider Dicerna Pharma (DRNA) announces elevation of J. Kevin Buchi to chairman January 24, 2019 7:38 AM - StreetInsider Dicerna Evolves Its Board of Directors to Support Continued Growth January 24, 2019 7:30 AM - BizWire Pre-Open Stock Movers 01/22: (EBAY) (UAA) (PANW) Higher; (ARNC) (PETS) (SWK) Lower (more...) January 22, 2019 9:28 AM - StreetInsider Chardan Capital Markets Upgrades Dicerna Pharmaceuticals (DRNA) to Buy January 22, 2019 6:46 AM - StreetInsider Form 8-K Dicerna Pharmaceuticals For: Jan 02 January 8, 2019 4:31 PM - SEC Filing Dicerna Pharmaceuticals, Inc. Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) January 8, 2019 4:05 PM - BizWire Form 4 Dicerna Pharmaceuticals For: Jan 02 Filed by: GREEN JOHN B January 4, 2019 9:11 PM - SEC Filing Form 4 Dicerna Pharmaceuticals For: Jan 02 Filed by: FAMBROUGH DOUGLAS January 4, 2019 9:10 PM - SEC Filing Form 4 Dicerna Pharmaceuticals For: Jan 02 Filed by: Weissman James B January 4, 2019 9:10 PM - SEC Filing Form 4 Dicerna Pharmaceuticals For: Jan 02 Filed by: Brown Bob D January 4, 2019 9:09 PM - SEC Filing Form 4 Dicerna Pharmaceuticals For: Jan 02 Filed by: ROSSKAMP RALF January 4, 2019 9:09 PM - SEC Filing Boehringer Ingelheim Exercises Option on Second Hepatic Disease Target from Research Collaboration with Dicerna January 4, 2019 7:00 AM - BizWire Boehringer Ingelheim Exercises Option on Second Hepatic Disease Target From Research Collaboration with Dicerna January 4, 2019 7:00 AM - BizWire Form 8-K Dicerna Pharmaceuticals For: Dec 31 January 4, 2019 6:08 AM - SEC Filing Form SC 13D Dicerna Pharmaceuticals Filed by: LILLY ELI & CO December 20, 2018 3:43 PM - SEC Filing Dicerna to Join NASDAQ Biotechnology Index December 20, 2018 7:30 AM - BizWire Dicerna Announces Closing of Global Licensing and Research Collaboration with Eli Lilly and Company December 19, 2018 7:30 AM - BizWire Full Article List